Operating Cash Flow ResilienceOperating cash flow rising to HKD 9.13M in 2025 provides durable liquidity to fund operations and modest capex without immediate external financing. That cash flow resilience supports continuity of care, reduces short-term funding pressure and gives time to execute strategic fixes.

Strong Free Cash Flow ConversionA strong free cash flow to net income ratio despite losses indicates efficient cash conversion and working capital management. This structural cash efficiency lowers urgency for dilutive financing, improves short-to-medium term liquidity, and helps sustain operations while margins recover.

Stable EBITDA MarginA small but positive EBITDA margin improvement to 13.9% signals operational discipline and cost control. Maintaining EBITDA amid revenue pressure suggests the business can protect operating cash flow, supporting near-term viability and offering a platform for margin recovery initiatives.

Bears Say

High Financial LeverageA debt-to-equity ratio of 5.44 and equity ratio of 7.3% indicate significant leverage and a thin equity cushion. This structure heightens refinancing and interest risks, limits financial flexibility, and amplifies downside if revenue or margins slip, challenging long-term stability.

Sharp Gross Margin DeclineA drop in gross margin from 80.2% to 50.7% is a material structural deterioration, likely from higher costs or pricing pressure. Sustained gross margin weakness erodes the base for profitability, forcing prolonged operational improvements or pricing action to restore durable earnings power.

Revenue Contraction And Sustained LossesAn 8.2% revenue decline coupled with three years of negative net margins reflects persistent demand or monetization issues. Continued top-line contraction with losses undermines scale benefits, hampers deleveraging, and increases reliance on cash reserves or external capital to fund operations.

8307 FAQ

What was Medicskin Holdings Ltd.’s price range in the past 12 months?

Medicskin Holdings Ltd. lowest stock price was HK$0.02 and its highest was HK$0.24 in the past 12 months.

What is Medicskin Holdings Ltd.’s market cap?

Medicskin Holdings Ltd.’s market cap is HK$78.55M.

When is Medicskin Holdings Ltd.’s upcoming earnings report date?

Medicskin Holdings Ltd.’s upcoming earnings report date is Jun 22, 2026 which is in 119 days.

How were Medicskin Holdings Ltd.’s earnings last quarter?

Medicskin Holdings Ltd. released its earnings results on Nov 24, 2025. The company reported HK$0 earnings per share for the quarter, the consensus estimate of N/A by HK$0.

Is Medicskin Holdings Ltd. overvalued?

According to Wall Street analysts Medicskin Holdings Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medicskin Holdings Ltd. pay dividends?

Medicskin Holdings Ltd. pays a Notavailable dividend of HK$0.025 which represents an annual dividend yield of N/A. See more information on Medicskin Holdings Ltd. dividends here

What is Medicskin Holdings Ltd.’s EPS estimate?

Medicskin Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medicskin Holdings Ltd. have?

Medicskin Holdings Ltd. has 396,736,000 shares outstanding.

What happened to Medicskin Holdings Ltd.’s price movement after its last earnings report?

Medicskin Holdings Ltd. reported an EPS of HK$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -23.684%.

Which hedge fund is a major shareholder of Medicskin Holdings Ltd.?

Currently, no hedge funds are holding shares in HK:8307

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medicskin Holdings Ltd.

Medicskin Holdings Ltd. (8307) is a leading healthcare company specializing in advanced dermatological and aesthetic solutions. The company operates in the medical and cosmetic sectors, offering a range of products and services designed to enhance skin health and appearance. Medicskin is known for its innovative skincare products, medical devices, and aesthetic treatments, catering to both consumers and healthcare professionals.